通过疾病管理计划推进心力衰竭治疗:改善结果的综合框架
Maha Inam1, Robert M Sangrigoli1, Linda Ruppert1
1Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19147, USA.
Journal of cardiovascular development and disease
|August 27, 2025
概括
心力衰竭疾病管理计划 (HF-DMP) 提供了一种结构化的方法,以改善患者的结果并降低成本. 这些项目包括医疗治疗,教育和支持系统,
科学领域:
- 心脏病学
- 公共卫生
- 医疗保健管理
背景情况:
- 心力衰竭 (HF) 是全球严重的健康负担,患病率,死亡率和再入院率很高.
- 目前的指导医学疗法 (GDMT) 单独不足以控制日益增长的HF流行.
- 一个全面的,多学科的方法对于有效的心力衰竭管理至关重要.
研究的目的:
- 审查心力衰竭疾病管理计划 (HF-DMP) 的基本组成部分.
- 突出优化HF护理和降低医疗成本的策略.
- 强调综合护理模式在应对心力衰竭方面的作用.
主要方法:
- 本综述综合了成功的HF-DMP的结构和组件的信息.
- 讨论的关键要素包括患者识别,风险分层和药物优化.
- 该审查还涵盖了以团队为基础的护理,过渡后续,远程监测和社会支持系统.
主要成果:
- 高频率DMP集成基于证据的疗法,患者教育和远程监测.
- 这些项目利用人工智能和社区卫生工作者支持等工具来实现可扩展性.
- 成功的HF-DMP专注于量身定制的干预措施,跨学科合作和健康公平.
结论:
- HF-DMP提供了一个可扩展的框架来增强心力衰竭护理.
- 优化结果和降低成本需要综合,多学科和以公平为导向的战略.
- 各种支持系统和技术的整合对于有效的疾病管理至关重要.
相关概念视频
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Cardiomyopathy VI: Nursing Management
32
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
32
Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21


